Corporate DisclosureBXPHARMA
BXPHARMA Corporate Disclosure — 14 November 2021
Announcement summary
- What happened
- BXPHARMA published a corporate disclosure on 14 November 2021. Read the full announcement for details.
- Company
- Beximco Pharmaceuticals PLC.
- Announcement published
Original announcement
(Cont. of BXPHARMA): The Company achieved 22.3% increase in sales in the reported first quarter as compared to the same period of prior year. Alongside gaining from the double-digit sales growth consistent to past p increase in sales in the reported first quarter as compared to the same period of prior year. Alongside gaining from the double-digit sales growth consistent to past periods, higher demand for the repurposed drugs for the Covid-19 treatment, (cont.)
Source & verification
- Source
- Published company disclosure
- Published through
- Dhaka Stock Exchange
- Announcement ID
- 61908aec03147376ea9301ac
- Original publication
- Last verified by BullBD
- Translation
- BullBD
More news from BXPHARMA
Financial information is provided for general reference only and may be revised by the company. BullBD is not the official DSE website. Not investment advice.